Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP8GR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,259
Award facts
- Contract value 100% obligated
- $24,259.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,259.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pens on December 30, 2025. This is an unset-aside, competitively awarded contract with performance expected to conclude by December 31, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supplier that serves military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. As a leading vendor in the federal pharmaceutical procurement space, the company maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The award of Zepbound, a GLP-1 receptor agonist used for weight management, reflects the company's role in supplying contemporary pharmaceutical products to support military healthcare programs. The firm fixed-price structure and rapid award-to-completion timeline indicate this is a routine replenishment order fulfilling established medical supply requirements within the broader pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DR26FP8GR?
SPE2DR26FP8GR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FP8GR worth?
The government has obligated $24,259 on SPE2DR26FP8GR.
Is contract SPE2DR26FP8GR an order under another contract?
Yes. SPE2DR26FP8GR is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8GR competed?
The extent of competition for SPE2DR26FP8GR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award